Publications by authors named "Awatef Jelassi"

Claim this Profile
S
Spectrum of Organic Aciduria Diseases in Tunisia: A 35-year Retrospective Study.
Awatef Jelassi, Fahmi Nasrallah, Emna Talbi, Mohamed Bassem Hammami, Rihab Ghodbane

Saudi J Med Med Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.
Rim Jbeli, Awatef Jelassi

EuroMediterr J Environ Integr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonketotic Hyperglycinemia in Tunisia. Report upon a Series of 69 Patients.
Fahmi Nasrallah, Sameh Hadj-Taieb, Amel Ben Chehida, Awatef Jelassi, Sana Ben Massoued

Neuropediatrics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene.
Mohamed Najah, Sarraj Mohamed Youssef, Hrira Mohamed Yahia, Slimani Afef, Jelassi Awatef

Diagn Pathol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.
Awatef Jelassi, Mohamed Najah, Afef Slimani, Imen Jguirim, Mohamed Naceur Slimane

Curr Genomics· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of two deletions in the LDLR gene in Tunisian patients with familial hypercholesterolemia.
Awatef Jelassi, Afef Slimani, Jean Pierre Rabès, Imen Jguirim, Marianne Abifadel

Clin Chim Acta· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Afef Slimani, Awatef Jelassi, Imen Jguirim, Mohamed Najah, Lamia Rebhi

Atherosclerosis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
Imen Jguirim-Souissi, Awatef Jelassi, Afef Slimani, Faouzi Addad, Majed Hassine

Coron Artery Dis· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
Awatef Jelassi, Afef Slimani, Imen Jguirim, Mohamed Najah, AbdelMajid Abid

Clin Chim Acta· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.
Mohamed Najah, Enza Di Leo, Jelassi Awatef, Lucia Magnolo, Jgurim Imene

Clin Chim Acta· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metalloproteinases: therapeutic target in atherosclerosis].
Imen Jguirim-Souissi, Awatef Jelassi, Mohamed Najah, Mustapha Rouis, Mohamed Naceur Slimane

Tunis Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
Imen Jguirim-Souissi, Awatef Jelassi, Faouzi Addad, Majed Hassine, Mohamed Najah

Am J Cardiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis